Related Experiment Video
Updated: Apr 30, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
Published on: November 8, 2015
ATF3 attenuates cyclosporin A-induced nephrotoxicity by downregulating CHOP in HK-2 cells
Yong-Min Choi1, Hey-Young Cho1, Muhammad Ayaz Anwar1
1Department of Molecular Science and Technology, Ajou University, Suwon 443-749, Republic of Korea.
Abstract:
Calcineurin inhibitors such as cyclosporin A (CsA) are widely used to treat organ transplantation-associated complications. However, CsA use is limited due to renal dysfunction. This study attempts to characterize the mechanism of CsA-induced nephrotoxicity using a human embryonic kidney cell line (HK-2). We performed microarray-based whole-genome expression analysis in HK-2 cells. CsA treatment induced the expression of endoplasmic reticulum (ER) stress-related and apoptosis-inducing genes at 6 and 24h, respectively, indicating that ER-stress predisposed the cells to apoptosis. G1 phase cell-cycle arrest was also observed via ER stress in CsA-treated cells. Furthermore, we found an inverse relationship between activating transcription factor 3 (ATF3), a stress-inducible protein, and C/EBP homologous protein (CHOP), an apoptosis-inducing protein. Moreover, when ATF3 knockdown cells were exposed to CsA, a prompt induction of CHOP was observed, which stimulated ROS production and induced cell death-related genes as compared to wild type. Taken together, our data demonstrate that ATF3 plays a pivotal role in the attenuation of CsA-induced nephrotoxicity by downregulating CHOP and ROS production mediated by ER stress.
Insights
Cyclosporin A (CsA) causes kidney damage by inducing endoplasmic reticulum (ER) stress and apoptosis. Activating transcription factor 3 (ATF3) protects against CsA nephrotoxicity by reducing CHOP and ROS production.
Area of Science:
- Nephrology
- Molecular Biology
- Cell Biology
Background:
- Calcineurin inhibitors like cyclosporin A (CsA) are crucial for preventing organ transplant rejection.
- CsA use is limited by its significant nephrotoxicity, necessitating a deeper understanding of its mechanisms.
- Kidney dysfunction is a major complication associated with CsA treatment.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying CsA-induced nephrotoxicity.
- To investigate the role of endoplasmic reticulum (ER) stress and apoptosis in CsA-mediated kidney damage.
- To identify potential protective factors against CsA nephrotoxicity.
Main Methods:
- Utilized a human embryonic kidney cell line (HK-2) for in vitro studies.
- Performed microarray-based whole-genome expression analysis to assess gene expression changes.
- Investigated the role of specific proteins (ATF3, CHOP) using knockdown experiments.
- Assessed reactive oxygen species (ROS) production and cell death markers.
Main Results:
- CsA treatment induced ER stress and apoptosis-related gene expression in HK-2 cells.
- ER stress led to G1 phase cell-cycle arrest in CsA-exposed cells.
- An inverse relationship was observed between ATF3 and CHOP expression.
- ATF3 knockdown exacerbated CsA-induced CHOP upregulation, ROS production, and cell death.
Conclusions:
- ER stress plays a critical role in CsA-induced nephrotoxicity and apoptosis.
- Activating transcription factor 3 (ATF3) acts as a protective factor against CsA nephrotoxicity.
- ATF3 attenuates CsA-induced kidney damage by downregulating CHOP and ROS production mediated by ER stress.
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Desensitization and Tachyphylaxis
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

